Covered recipient · General Payments record
ZACHARY M HURWITZ
Allopathic & Osteopathic Physicians Surgery Surgery of the Hand
General Payments · PY2018–2024
$10,206.69
- Reported across 134 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,624.55 | 30 |
| Travel and Lodging | $477.30 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Pylant Medical | $459.89 | 6 |
| Arthrex, Inc. | $400.65 | 7 |
| AXOGEN | $193.94 | 3 |
| Acera Surgical, Inc. | $158.61 | 1 |
| Stryker Corporation | $153.63 | 1 |
| PolyNovo North America LLC | $147.13 | 1 |
| Smith & Nephew, Inc. | $141.98 | 5 |
| TELA Bio, Inc. | $135.02 | 1 |
| Endo USA, Inc. | $126.69 | 1 |
| REVANCE THERAPEUTICS, INC. | $54.31 | 1 |
| ORGANOGENESIS INC. | $39.56 | 1 |
| ABBVIE INC. | $33.53 | 1 |
| CooperSurgical, Inc. | $24.13 | 1 |
| MOTIVA USA, LLC | $17.90 | 1 |
| Bioventus LLC | $14.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.53 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957772 | CMS |
| Acera Surgical, Inc. | $158.61 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152415476 | CMS |
| Arthrex, Inc. | $238.65 | 12/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1146525465 | CMS |
| Arthrex, Inc. | $24.00 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146525461 | CMS |
| Arthrex, Inc. | $10.00 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146525442 | CMS |
| Arthrex, Inc. | $34.00 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146525446 | CMS |
| Arthrex, Inc. | $50.00 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146525449 | CMS |
| Arthrex, Inc. | $10.00 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146525453 | CMS |
| Arthrex, Inc. | $34.00 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146525457 | CMS |
| AXOGEN | $126.58 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143636208 | CMS |
| AXOGEN | $36.86 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143639498 | CMS |
| AXOGEN | $30.50 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143640264 | CMS |
| Bioventus LLC | $14.88 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137442294 | CMS |
| CooperSurgical, Inc. | $24.13 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150792071 | CMS |
| Endo USA, Inc. | $126.69 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138582185 | CMS |
| MOTIVA USA, LLC | $17.90 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139155402 | CMS |
| Organogenesis Inc. | $39.56 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145432200 | CMS |
| PolyNovo North America LLC | $147.13 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148181065 | CMS |
| Pylant Medical | $80.99 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126525723 | CMS |
| Pylant Medical | $35.82 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126525725 | CMS |
| Pylant Medical | $35.26 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126525733 | CMS |
| Pylant Medical | $238.65 | 12/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1126525727 | CMS |
| Pylant Medical | $64.77 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126525729 | CMS |
| Pylant Medical | $4.40 | 12/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126525731 | CMS |
| REVANCE THERAPEUTICS, INC. | $54.31 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147920618 | CMS |
| Smith+Nephew, Inc. | $13.38 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149579271 | CMS |
| Smith+Nephew, Inc. | $7.36 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149579269 | CMS |
| Smith+Nephew, Inc. | $15.37 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149579273 | CMS |
| Smith+Nephew, Inc. | $101.69 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149579275 | CMS |
| Smith+Nephew, Inc. | $4.18 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149579267 | CMS |
| Stryker Corporation | $153.63 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119861239 | CMS |
| TELA Bio, Inc. | $135.02 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154273163 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.